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Abstract
Introduction A subtrochanteric proximal femur fracture occurs in the 5 cm of bone immediately distal to the lesser trochanter. 
UK national guidelines advise that adults with subtrochanteric fractures should be treated with an intramedullary nail (IMN). 
This study aims to compare peri-operative outcome measures of patients with subtrochanteric fractures treated with either 
an IMN or a dynamic hip screw (DHS) construct.
Materials and Methods We retrospectively reviewed subtrochanteric fractures presenting at our institution over 4.5 years 
(October 2014–May 2019), classifying them into two treatment groups; IMN and DHS. These groups were compared on 
outcome measures including surgical time, blood loss, radiation dose area product (DAP), length of stay, re-operation rate 
and mortality.
Results During the time period studied, 86 patients presented with a subtrochanteric fracture of the femur; with 74 patients 
(86%) receiving an IMN and 12 (14%) receiving a DHS. The comparative outcome measures reaching statistical significance 
were blood loss and radiation DAP. The DHS group showed a significantly lower mean blood loss of 776 ml compared to 
1029 ml in the IMN group. Also, the DHS group showed a significantly lower mean DAP of 150.30 mGy cm2 compared to 
288.86 mGy cm2 in the IMN group.
Conclusion Although UK national guidelines recommend treating all subtrochanteric fractures with an IMN; the outcome 
measures assessed in our study did not show use of an IMN to be superior to a DHS. The DHS group showed a lower esti-
mated blood loss and a reduced DAP. This, along with the reduced financial cost associated with a DHS, may support the 
use of DHS over IMN for certain subtrochanteric fractures of the femur. There may not be a single favourable implant for 
the treatment of subtrochanteric fractures as a whole; instead different subtypes of fracture may be amenable to a number 
of fixation devices. Choice of implant should be determined locally and based on existing and future clinical and health 
economic research.
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Introduction
Hip fractures are the most common reason for admission 
to an orthopaedic ward in the United Kingdom (UK), with 
over 86,000 occurring every year [1]. The majority of hip 
fractures are due to ‘fragility’ fractures in older people with 
osteoporosis or osteopenia presenting after a fall [2]. This 
is reflected in the average age of people presenting with hip 
fractures being 77 [2]. The population of the UK and sev-
eral other countries is becoming increasingly older, which is 
only likely to exacerbate the prevalence of such fractures [3]. 
This, together with the fact that the combined cost of medi-
cal and social care for all hip fracture presentations in the 
UK amounts to around £1 billion means that the appropriate 
management of such fractures, is of crucial importance [2].
Hip fractures are often grouped into intracapsular or ext-
racapsular fractures. Our study will focus on the extraca-
psular group and more specifically on the subtrochanteric 
fractures. These fractures affect the region of the proximal 
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femur within five centimetres distal to the lesser trochanter. 
They account for around 5% of proximal femur fractures and 
previous studies report a bi-modal age distribution consist-
ing of young adults involved in high energy traumas and 
older patients with osteoporosis [4, 5].
The UK national guidelines currently state that all subtro-
chanteric fractures should be treated using an intramedullary 
nail (IMN) [2]. This is due to concerns with reported high 
rates of femoral medial displacement, non-union and sub-
sequent re-operation in those with unstable subtrochanteric 
fractures treated using a dynamic/sliding hip screw (DHS). 
However, the DHS remains a method for fixation in subtro-
chanteric fractures, with several surgeons continuing to use 
it due to its ability to provide compression along the femoral 
neck as well as load sharing between the bone and implant 
[6–8]. UK national guidelines, however, recommend that 
such extramedullary implants only be used in the treatment 
of adults with trochanteric fractures above and including 
the lesser trochanter [2]. This study aims to compare some 
peri-operative outcome measures of a group of patients with 
subtrochanteric fractures treated with either an IMN or a 
DHS construct.
Materials and methods
Using the National Hip Fracture Database, we retrospec-
tively reviewed all patients presenting with a hip fracture 
to our major trauma centre over a 4.5-year period (October 
2014–May 2019). We selected the patients presenting with a 
subtrochanteric fracture specifically and used the electronic 
patient record system to gather relevant data about each 
patient. Patients were first grouped based on the treatment 
received—IMN or DHS. Demographic data were collected 
including patient age, gender, laterality, Body mass index 
(BMI) and American Society of Anaesthesiologists (ASA) 
physical status classification. All fractures were classified 
using the Seinsheimer classification system [9]. This system 
classifies subtrochanteric fractures into one of 8 possible 
subtypes and has been used in a number of similar previous 
studies [10–14]. Fracture stability was defined according to 
wang et al., which considers Seinsheimer type i and ii frac-
tures as stable and type iii, iv and v fractures as unstable 
[15].
All operations were performed at a Major Trauma Centre 
by either a consultant orthopaedic surgeon or an orthopaedic 
trainee supervised by a consultant. Due to the retrospective 
nature of this study, we were unable to define a -priori cri-
teria outlining specific situations in which a DHS or IMN 
should be used. Instead implant choice was determined by 
personal surgeon preference and experience. Pre-opera-
tive antibiotics were administered in all cases. All IMNs 
used were long (300–460 mm) intramedullary titanium 
trochanteric fixation nails (Synthes) with proximal lag and 
distal locking screws. In those patients receiving a DHS, a 
dynamic hip screw system (Synthes) with a standard 38 mm, 
135° barrel was used along with a dynamic compression 
plate containing between 5 and 10 holes through which 4.5-
mm cortical screws were inserted. All procedures were per-
formed on a traction table under intra-operative fluoroscopic 
guidance. Post-operatively, all patients received thrombo-
prophylaxis and antibiotic treatment as per department pro-
tocol. Full blood count and urea and electrolyte blood tests 
were performed, and patients received regular physiotherapy 
and orthogeriatric review. Sutures or clips were removed 
14 days post-operatively.
Further comparative data collected included the length 
of operation and inpatient stay, pre-/post-operative abbre-
viated mental test score (AMTS), 30-day mortality, 1-year 
mortality, dose area product (DAP) of the intra-operative 
fluoroscopy, complications and re-operations.
Pre- and post-operative haemoglobin (Hb) concentrations 
were also collected with the aim of calculating blood loss 
during the surgical procedure using the Haemoglobin dilu-
tion method, as described by Good et al. [16]. This method 
previously used by other studies for orthopaedic procedures 
is based on the premise that following a period of blood loss, 
fluid moves from the extravascular tissues into the blood 
vessels in order to restore blood volume, thus lowering Hb 
[16, 17]. The difference between pre- and post-operative Hb 
can then give an indication of the degree of blood loss that 
has occurred. The equation used assumes that the patient is 
euvolemic during the point at which pre- and post-op hae-
moglobin measurements are taken. Authors disagree about 
the time it takes for enough fluid to replace any blood lost 
and as such there is no standard time point used to deter-
mine post-op haemoglobin concentration. Previous research 
has used haemoglobin concentration measurements taken 
between the 3rd and 4th day after surgery [18]. This study 
aimed to use haemoglobin concentration on the fourth day 
after surgery; however, as patients did not have daily hae-
moglobin concentration measurements, this was not always 
the case. As such, if the haemoglobin concentration on the 
fourth day after surgery was not available, the next nearest 
measurement was used.
The equation used requires an estimation of the patient’s 
blood volume which was calculated using Nadler’s equation 
[19]. For two patients Nadler’s equation could not be used as 
weight/height data were not available and so average blood 
volume values for their respective sex were used as based 
on Enson et al. [20]. For three patients, weight data were 
available, but height/BMI data could not be found and so 
Gilcher’s rule of five was used where weight was multiplied 
by an expected blood volume per kg of body mass.
Statistical analysis was performed using IBM SPSS statis-
tics 25. Welch’s t-test was used to compare mean values for 
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operation length, DAP, blood loss and hospital stay between 
the two groups. Welch’s t-test was chosen before analysis 
of normality and homogeneity of variance due to the large 
difference in patient number in each treatment group. Analy-
sis of normality using the Kolmogorov–Smirnov test and 
visual inspection of normal Q-Q plots revealed all data were 
normally distributed except for the length of stay values for 
the IMN group. Due to the extent of the non-normality in 
this group, the nonparametric Mann–Whitney U test was 
instead chosen to analyse length of stay data. Fisher’s exact 
test was used to test for significant differences between the 
groups with respect to categorical variables such as number 
of patients requiring blood transfusion and discharge des-
tinations. Statistical significance was defined as P < 0.05.
Results
A total of 1808 patients presented to our centre with a neck 
of femur fracture during the study period. Out of these 
patients, 86 suffered a subtrochanteric fracture of the femur, 
with 74 patients receiving an IMN and 12 receiving a DHS. 
Mean age was 84 (standard deviation: 8.89, range: 62–96) 
in the IMN group and 85 (standard deviation: 12.01, range: 
64–99) in the DHS group. Gender distribution was 81% 
female and 19% male in the IMN group compared to 75% 
female and 25% male in the DHS group. In both groups, the 
majority of patients were admitted from home and received 
surgery within 36 h of admission (Table 1). The proportion 
of stable and unstable fractures was similar in both groups.
The mean operative time in the IMN group was 106 min 
(95% CI: 97.76–114.60) compared to 100 min (95% CI: 
70.95–129.71) in the DHS group (Table 2). This differ-
ence was not statistically significant (P = 0.683). The 
mean DAP was significantly higher (P = 0.000184) in the 
IMN group with a mean value of 288.9 mGy cm2 (95% 
CI: 236.26–341.47) compared to 150.3 mGy cm2 (95% 
CI: 102.07–298.53) in the DHS group. There was also a 
significant difference in the mean blood loss between 
the two groups, with the IMN group showing a signifi-
cantly higher (P = 0.042) mean blood loss of 1029  ml 
(95% CI: 909.42–1148.07) compared to 776.ml (95% CI: 
540.69–995.90) in the DHS group. Of those patients treated 
with an IMN, 54% required a blood transfusion in the five 
days following their operation. This figure was only 33% 
for those receiving a DHS; however, the difference was not 
statistically significant (P = 0.223). Furthermore, 10.8% 
of patients in the IMN group required a blood transfusion 
of greater than 2 units in the first five days following their 
operation. Whilst this was higher than the equivalent value 
for the DHS (0%), the difference did not show statistical 
significance (P = 0.593).
In the IMN group, a total of seven patients required re-
operation. Deep infection requiring washout occurred in two 
patients, whilst implant failure due to proximal screw cut out 
occurred in four. A further patient required re-operation due 
to initial sub-optimal fixation and positioning of the nail. 
One case of implant failure on the background of a peri-
prosthetic fracture accounts for the single re-operation in 
the DHS group. None of the differences in re-operation and 
complication rates between the two groups were found to be 
statistically significant (Table 2). No statistically significant 
differences were found in the number of patients receiv-
ing an open or closed reduction between the two groups. 
Reduction of the fracture in all 86 patients was deemed to 
be adequate.
Table 1  Pre-operative characteristics of patients in both treatment 
groups
Descriptors Intramedullary nail Sliding hip screw
Total N = 74 (%) Total N = 12 (%)
Male, n 14 (18.92) 3 (25.00)
Female, n 60 (81.08) 9 (75.00)
Median age, years 84 85
Right-sided fracture, n 33 (44.59) 6 (50.00)
Left-sided fracture, n 41 (55.41) 6 (50.00)
Seinsheimer classification
1 2 (2.70) 0 (0.00)
2A 4 (5.41) 0 (0.00)
2B 28 (37.84) 3 (25.00)
2C 7 (9.46) 3 (25.00)
3A 16 (21.62) 4 (33.33)
3B 6 (8.12) 0 (0.00)
4 4 (5.41) 1 (8.33)
5 7 (9.46) 1 (8.33)
Total stable 41 (55.41) 6 (50.00)
Total unstable 33 (44.59) 6 (50.00)
Pre-operative ASA (mean) 2.96 3.17
Unknown 6 (8.11) 1 (8.33)
1 1 (1.35) 0 (0)
2 15 (20.27) 1 (8.33)
3 38 (51.35) 7 (58.33)
4 14 (18.92) 3 (25.00)
Mean pre-operative AMTS 7.47 7.64
Mean post-operative AMTS 7.17 6.5
Body Mass Index 24.25 26.02
Residence
Own home 66 (89.19) 10 (83.33)
Nursing care 3 (4.05) 1 (8.33)
Residential care 5 (6.76) 1 (8.33)
Treatment delay
 < 36 h 61(82.43) 11 (91.66)
 > 36 h 13 (17.57) 1 (8.33)
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The DHS group showed a trend towards shorter mean 
hospital stay of 12 days (95% CI: 8.52–15.65) compared to 
patients in the IMN group with a mean stay length of 19 days 
(95% CI: 15.58–22.30); however, this difference was not sta-
tistically significant (P = 0.128). There were differences in the 
discharge destination of patients between the two treatment 
groups as shown (Table 2); however, none of these differences 
showed any statistical significance.
In the IMN group, 3 patients (4%) died in the first 30 days 
following their operation compared to 2 (17%) in the DHS 
group. This difference was not statistically significant 
(P = 0.141). On the other hand, the IMN group showed a 
higher 1-year mortality with 18 patients (24%) dying within 
a year after their operation compared to 3 in the DHS group 
(25%). Again, this difference was not shown to be statistically 
significant (P = 1.00).
Discussion
The treatment of subtrochanteric hip fractures is com-
plex and technically challenging. This is partly due to the 
unique biomechanical and anatomical characteristics of 
the subtrochanteric area. The main structural support to 
this region is the calcar—a posteromedial bone element 
beginning distal to the lesser trochanter, travelling to the 
posteroinferior femoral neck. Koch found that this region 
can experience up to 1200 N of force in a 200 lb man when 
standing [21]. Furthermore, the subtrochanteric region 
experiences high stress levels due to the insertion of the 
hip abductors, iliopsoas tendon and short external rotators 
in the region. This along with the region’s poor vascu-
lar supply due to the extensive thick cortical bone makes 
Table 2  Peri-operative outcome data for the two treatment groups
Values for number of patients requiring any blood transfusion and blood transfusion > 2 units only include patients who received these transfu-
sions in the five days immediately following surgery
Descriptors Intramedullary nail (95% CI) Dynamic hip screw
(95% CI)
P value
Mean operation time (minutes) 106.18 (97.76–114.60) 100.33 (70.95–129.71) 0.683
Mean DAP (mGy.cm2) 288.86 (236.26–341.47) 150.30 (102.07–298.53) 0.000
Mean blood loss (ml) 1028.74 (909.42–1148.07) 776.19 (540.69–995.90) 0.042
Mean total stay (days) 18.95 (15.58–22.30) 12.08 (8.52–15.65) 0.128
Re-operation (%)
Implant failure 4 (5.41) 1 (8.33) 0.538
Infection 2 (2.70) 0 (0) 1.00
Sub-optimal fixation 1 (1.35) 0 (0) 1.00
Total 7 (9.46) 1 (8.33) 1.00
Reduction
Open 54 (72.97) 9 (75.00) 1.00
Closed 20 (27.03) 3 (25.00) 1.00
Number requiring blood transfusion (%) 40 (54.05) 4 (33.33) 0.223
Number requiring blood transfusion > 2 Units (%) 8 (10.81) 0 (0) 0.593
Discharged to (%)
Own home 32 (43.24) 3 (25.00) 0.345
Nursing care 6 (8.11) 1 (8.33) 1.00
Rehabilitation unit 28 (37.84) 5 (41.67) 1.00
Residential care 5 (6.76) 1 (8.33) 1.00
Died at hospital 3 (4.05) 1 (8.33) 0.458
Mortality (%)
30 days post-op 3 (4.05) 2 (16.67) 0.141
1 year post-op 18 (24.32) 3 (25.00) 1.00
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the successful management of subtrochanteric fractures 
extremely difficult [22].
We found that at our centre, there was general adher-
ence to UK national guidelines, with 74 subtrochanteric 
fractures (86%) being treated with an IMN. Patients in both 
treatment groups were similar in terms of demographic and 
pre-operative characteristics such as age, BMI, ASA grade 
and AMTS score. Interestingly, the majority of patients in 
both groups were female (81% In IMN group, 75% in DHS 
group). This is in agreement with previous work which have 
shown up to a 33% higher incidence of subtrochanteric frac-
tures in females compared to males [23]. The reason for this 
increased incidence in females is unknown and could serve 
as a potential area worthy of further research.
Blood loss
Studies have shown large amounts of hidden blood loss dur-
ing intramedullary nailing, DHS insertion and other ortho-
paedic surgeries [17, 18]. As a result, when calculating 
blood loss, it was important to use a formula that estimated 
total blood loss rather than simply measuring volume of 
blood collected during surgery. A study by Gao et al. details 
four different methods for calculating surgical blood loss 
during a total knee arthroplasty, suggesting that the haemo-
globin dilution method is the most accurate and so this was 
chosen [24].
Blood loss estimation using the above method showed 
a significantly lower mean blood loss for the DHS group 
(776 ml) compared to the IMN group (1029 ml). This is of 
particular importance in treatment of subtrochanteric frac-
tures as the majority of patients are elderly with the average 
age in the studied cohort being 83 years. Anaemia has been 
identified as a risk factor for both morbidity and mortality 
in this elderly group and as such this significantly lower 
blood loss in the DHS group is of clinical benefit [25]. Fur-
thermore, only 33% of those treated with a DHS required a 
blood transfusion in the five days following their operation, 
compared to 54% in those treated with an IMN. Although 
this difference was not found to be statistically significant 
(P < 0.05), it is worthwhile to note as another potential ben-
efit of DHS use, particularly as blood transfusions have been 
associated with an increased risk of complications such as 
infection after surgery [26].
Radiation exposure
Our results agree with a similar study whereby mean DAP 
was found to be significantly lower for patients treated with 
a DHS compared to an IMN [27]. The use of fluoroscopic 
image intensifiers in orthopaedics and the known pathologi-
cal effects of radiation exposure continue to raise concerns 
as to their safety for both the patient and theatre staff [28]. 
To this end, DAP values were collected in order to assess 
the radiation risk patients endured. It represents the absorbed 
dose multiplied by the body area irradiated and so is a better 
indicator of overall risk than total radiation dose. Therefore, 
a potential advantage of using a DHS over an IMN to treat 
subtrochanteric fractures is a reduced risk of the pathologi-
cal effects of exposure to ionising radiation. However, Malek 
et al. found that the risk of pathological radiation injury due 
to fluoroscopy in lower limb trauma operations is small and 
so the benefit of DHS in terms of radiation exposure may 
be of limited clinical benefit [28]. Nevertheless, according 
to Ionising Radiation (Medical Exposure) Regulations 2017 
Guidelines patient exposure to radiation should be mini-
mised wherever possible and using a DHS may help to do 
so [29].
All other outcome measures collected show no statisti-
cally significant difference between either of the two treat-
ment groups. This may, in part, be due to the very small 
number of patients in the DHS group. Although this is 
understandable as current guidelines favour the use of an 
IMN, a larger DHS group may have revealed more statistical 
significance in the results. Another limitation of this study 
is the retrospective nature of the data collection and the lack 
of patient-reported outcome measures.
Current national guidelines recommend the use of IMN 
for the management of all subtrochanteric fractures. Upon 
further inspection of the guidelines, it becomes clear that 
this is due to concerns with reportedly high rates of non-
union following treatment of subtrochanteric fractures 
with a DHS. This conclusion is based on two studies inves-
tigating the use of IMN’s compared to DHS in subtrochan-
teric fractures. The first by Ekstrom et al. finds that only 
1/13 patients treated by DHS showed non-union, whilst 
0/19 of those treated with an IMN showed non-union [30]. 
The second study conducted by Rahme et al. found that 
8/29 treated with a DHS showed non-union, whilst this 
figure was 0/29 for those treated with an IMN [31]. The 
guidelines are currently based on only two studies with 
relatively small samples sizes and one of which shows a 
very minor difference in non-union, even concluding that 
there were no differences in the functional outcome and 
complication rates between the two treatment groups and 
even that the patients treated with a DHS showed a lower 
re-operation rate [30]. Unfortunately, due to department 
policy, there is a lack of routine follow-up for patient’s 
presenting with neck of femur fractures at our centre and 
so it was not possible to assess fracture union in our retro-
spective study. However, patients who had specific prob-
lems/concerns following surgery were followed up, with 
none of these patients showing any evidence of non-union. 
Previous studies have also shown no significant difference 
in union between IMN and DHS patients and we would 
suggest that these differing results in the literature make it 
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difficult to draw a definitive conclusion about differences 
in union rates between the two implants [10, 30]. Further-
more, both groups showed similar results in terms of post-
operative complications, with no significant differences 
found in total rate of re-operation and implant failure.
Cost analysis by the UK National Institute for Health and 
Care Excellence (NICE) reveals a large difference in the 
cost of the two implants, with the average price of a DHS 
implant being £252.51 compared to an average of £1,175.50 
for a long IMN [2]. Of course, differences in cost should 
not play a part in clinical decision making should there be 
any significant clinical difference in favour of the use of a 
particular implant. However, the results of this study fail to 
show any such significant differences in favour of use of the 
IMN and in fact indicate that DHS may perform better in 
terms of important variables such as blood loss and radiation 
exposure. The DHS group showed a trend towards having 
a lower mean length of hospital stay than the IMN group. 
Although this difference was not shown to be significant 
in our cohort, it is worthy of note as a shorter hospital stay 
combined with reduced cost of the implant itself is a major 
economic advantage of treatment with a DHS.
One key problem with the treatment of subtrochanteric 
fractures that might contribute to the difference of opinions 
in the literature is the lack of a consistently used, universally 
accepted classification system. Three systems are currently 
commonly used: the AO/OTA system, the Russell-Taylor 
System and the Seinsheimer system which makes it hard to 
compare the results of different studies and put into place 
recommended guidelines for different subtypes of subtro-
chanteric fractures. Developing a universally used system 
could prove to be key in improving treatment as biome-
chanical studies have shown that dynamic hip screws and 
intramedullary nails have differing stability when used in 
different subtypes of subtrochanteric fractures. Wang et al. 
found that the DHS needed integrity of the medial subtro-
chanteric cortex as in stable Seinsheimer fracture types I and 
II in order to provide stable fixation [15]. In these situations, 
the DHS lateral plate was able to act as a ‘tension band’ 
allowing tension stress to be transmitted to the intact medial 
cortex. However, in situations where the medial subtrochan-
teric cortex is not intact as in unstable Seinsheimer type III 
and IV fractures, this stress is transferred to the lateral side 
plate of the DHS leading to bending of the plate and high 
compression stress on the lateral cortex of the femur and 
subsequent implant failure. It was determined that in such 
situations, IMNs biomechanically perform much better and 
are able to provide stable fixation as stress can be transmit-
ted through the nail to the distal femur rather than the weak 
subtrochanteric cortex. However, these data are yet to be 
tested in a clinical setting and further research should be 
conducted into determining the suitability of both implants 
in different subtrochanteric fracture subtypes.
It must be acknowledged that this study is not without 
limitations. For example, the number of patients treated 
with a DHS is small, which may lead to a lack of statistical 
power. However, the studies currently used to inform UK 
national subtrochanteric fracture management guidelines 
suffer from a similar problem, with only 13 and 29 patients 
in the DHS group, respectively. Furthermore, our study 
cohort includes 74 patients treated with an IMN, compared 
to the smaller numbers of 19 and 29 seen in these previous 
studies. The retrospective nature of this study, together 
with the lack of regular follow-up, as is standard practice 
in the UK for this patient cohort, means we were not able 
to collect further follow-up data such as fracture union and 
time to full weight bearing, or set clear a-priori criteria for 
situations in which an IMN or DHS should be used. Due 
to the above limitations, we cannot draw any firm conclu-
sions form this study; however, it is important to challenge 
existing practices to improve patient outcomes in a contin-
uously challenging economic environment for healthcare. 
The current UK guidelines on treatment of subtrochanteric 
fractures may be too rigid and based on limited evidence.
Conclusion
Although current national guidelines in the UK recom-
mend treating all subtrochanteric fractures with an IMN, 
the outcome measures we assessed in our study did not 
demonstrate that treating these fractures with an IMN was 
superior to using a DHS. Furthermore, the DHS group 
showed a lower estimated blood loss and a reduced DAP. 
This, along with the reduced financial cost associated with 
DHS, may support the use of DHS over IMN for certain 
subtrochanteric fractures of the femur. There may not be 
a single favourable implant for the treatment of subtro-
chanteric fractures as a whole; instead, different subtypes 
of fracture may be amenable to the use of a different fixa-
tion device. Adoption of a universal fracture classifica-
tion system for subtrochanteric fractures may aid in the 
development of specific guidelines for these different frac-
ture subtypes and the optimum fixation construct. With an 
ageing population during a period of increasing financial 
restraints on a national health service, our national guide-
lines for fracture fixation should evolve with emerging 
evidence and provide comprehensive guidance to shape 
surgical practice.
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